iCAD

“With FDA clearance of ProFound Detection Version 4.0, iCAD continues to set new benchmarks in cancer detection, especially in the most challenging cases where accurate and early detection is critical,” said Dana Brown, President and CEO, iCAD. “This groundbreaking fourth generation of our AI solution not only enhances detection for cancers feared most by even the expert fellowship-trained breast radiologists, but also reduces the burden of potential false positives, thereby providing clinicians with a highly precise and efficient AI concurrent-reader solution. See it in Action! Schedule an #RSNA2024 demo: https://bit.ly/4fVe8F3 #ProFoundAI #BreastAI #WhatsNextInAI

CancerIQ is excited to join iCAD’s booth for another year at Radiological Society of North America (RSNA) 2024, where we’ll showcase our collaboration to deliver the most advanced and comprehensive breast health care solution for radiology teams. When: December 1–5, 2024 Where: RSNA, Chicago, IL – iCAD Booth 4747 Will we see you there? RSVP below ? PS: Stay tuned for some big news on Monday from CancerIQ!

[#RSNA2024] Precise Detection starts with Quality Images. Stop by the iCAD booth and Densitas Inc. booth to see ProFound AI Breast Health Suite and intelliMammo side-by-side on Monday & Tuesday at RSNA. Learn how iCAD and Densitas Inc. help imaging centers elevate patient care with their existing equipment through quality images and precise detection. ?? Densitas booth #2806 Monday 12/2 at 10:00 am ?? iCAD booth #4747 Tuesday 12/3 at 10:00 am https://bit.ly/4eqwpcd #iCADPartners #intelliMammo #ProFoundAI #BreastAI #RadiologyAI

[#RSNA2024] ?? Reminder! Join us on Sunday Dec 1 in Chicago for AI in the Sky, iCAD’s Appreciation Event. We’ll be talking about what’s new in Breast Health AI and enjoying time to get to know each other outside the business of the tradeshow floor. RSVP: https://bit.ly/4fnDoEh #BreastAI #WhatsNextInAI #ProFoundAI

?????????????? ?????????????????? ???????????? ???????? ?????????????? ????????????. Our operational AI platform that includes intelliMammo? and ????????????????????????? GPT AI assistant, together with iCAD’s AI-powered Breast Health Suite, provide a holistic state-of-the-art solution for image quality, accurate and precise early cancer detection, and personalized patient care. Visit the Densitas and iCAD booth at #RSNA24 for a live demonstration of how our solutions work together. Join us for a live demo: ?? Densitas booth #2806 on Monday, 12/02 at 10:00 am ?? iCAD booth #4747 on Tuesday, 12/03 at 10:00 am Book a demo: https://lnkd.in/evYBjv4n #OperationalEfficiency #ArtificialIntelligence? #OperationalAI #Mammography #AI #Radiology #BreastCancer

[#RSNA2024] In the newly FDA Cleared ProFound Detection v4 – the next generation of Breast AI, radiologists can see a 22% overall improvement in detecting some of the most challenging and aggressive cancer subtypes compared to v3. Specific Detection Improvements include: ?? 60% in invasive lobular cancers ?? 21% in invasive cancers ?? 38% in cancers smaller than 1cm ?? 50% within dense breasts Source: iCAD Regulatory Data Comparisons of ProFound Detection v3 and v4 on Hologic Standard DBT. May not be available in all geographies. Schedule an RSNA Demo: https://bit.ly/40KrU95 #ProFoundAI #BreastAI #WhatsNextInAI

iCAD 3Q 2024 Earnings Recap: We’re excited to highlight our Q3 financial results! We continue to see growth driven by strong momentum in our SaaS transformation and geographical expansion of our AI-powered breast health solutions. Key Highlights: ?? ARR: $9.3M, up 10% YoY ?? Total Revenue: $4.2M, up 4% YoY ?? Announced FDA Clearance of ProFound Detection v4.0 We saw strong traction in the quarter from our ProFound Cloud SaaS platform, which continues to gain market recognition and resulted in the close of 52 perpetual deals, 20 subscription deals, and 13 cloud deals in the quarter. Thank you to our team and partners for your hard work this quarter. Together, we’re creating a world where cancer can’t hide. Read more: https://bit.ly/48M6U40

Healthcare's challenges are too complex for any one stakeholder to tackle alone! At GE HealthCare we believe in the power of collaboration and partnership. Join us at RSNA 2024 and visit our Expert Corner to meet our subject matter experts, technology partners, and GE HealthCare specialists! In our interactive space, you'll find cutting-edge solutions like Enterprise Imaging in the Cloud. Discover how we, along with partners like Amazon Web Services (AWS), Blackford, iCAD, Riverain Technologies, GLEAMER, Smart Reporting GmbH, and others are enhancing the healthcare professional's experience. Equip your team with the technology and speed needed to deliver improved care. Here's what you can expect: ?? Live demos of enterprise imaging solutions ?? Expert consultations on integrating AWS ?? Opportunities to connect with like-minded professionals Visit us at the event and see how our partnerships are transforming medical imaging for the future. ?? Book your meeting now: https://lnkd.in/eDfzUWT7 See you in the Windy City! #RSNA2024 #GEHealthcare #AWS #Partnership

Join us at RSNA 2024! Explore the Expert Corner Workstation with our great partners and GE HealthCare experts! This interactive space will feature cutting-edge solutions, including Enterprise Imaging in the Cloud. Equip your team with the technology and speed to help deliver improved care. What to expect: ?? Live demos of enterprise imaging solutions ?? Expert consultations on integrating AWS ?? Opportunities to connect with like-minded professionals Visit us at the event and discover how our partnership is transforming medical imaging for the future. ?? Book your meeting now: https://lnkd.in/eFKBcDyQ Amazon Web Services (AWS), Blackford, Smart Reporting GmbH, iCAD, Riverain Technologies, GLEAMER & more Bernadette Angerer, Kristin Escobar, Jim Moulton, Debbie Wang, Jeremiah R. Bennett, Allen Hundley, Daniel F Jones, Georgio Francis, Senad Sekic, Sigrid Auweter #RSNA2024 #GEHealthcare #AWS #AWSPartners #Partnership

[#ProFoundCaseStudy] In this client case study, Dr. Axel Gr?wingholt highlights his team’s initial challenges that led them to adopt the ProFound AI Breast Health Suite, and details their outstanding results. He summarized that in addition to their improved detection, they found: “The group’s radiologists also appreciate the solution because it offers a back-up for their own performance, particularly if they face the reality of their busy workday, which includes many interruptions that could potentially cause them to overlook something of importance. For us, it’s not only important to be a center where cancer is reliably detected. From the efficiency point of view, it’s also important to reduce the long reading times commonly associated with DBT. With iCAD’s ProFound AI solution, we can free up our radiologists to focus on the more difficult cases and help minimize misdiagnoses or mismanagement.” ?? Read the Case Study: https://bit.ly/3UIEcLnf